This site is intended for health professionals only
Sunday 16 June 2019
Share |

Trial for novel schizophrenia treatment

Lundbeck has initiated phase II trials with the compound Lu AE58054 for the treatment of schizophrenia.
 
Lu AE58054 has shown positive results in a number of preclinical trials, which documented the compound's ability to improve cognition.

The compound affects different areas of the brain from traditional antipsychotics, and so can be used to complement existing treatments. Consequently, Lundbeck expects that Lu AE58054 will improve the daily functioning of the patients, for example, improving their ability to solve practical problems in their daily lives.

Based on the positive preclinical data and positive outcomes of phase I trials in healthy individuals, Lundbeck has now launched a phase II trial with two treatment groups of 60 patients each.

The first group will receive treatment with risperidone and placebo, while the other will receive risperidone and Lu AE58054. The treatment period will run for three months.

Preliminary results are expected by the end of 2009.
 
"I'm very pleased that we're able to commence trials with a novel treatment of schizophrenia, which is a severe disorder," says Executive Vice President Anders Gersel Pedersen, Head of Drug Development at Lundbeck.
 
Lundbeck acquired the global rights to Lu AE58054 in connection with the acquisition of US biotech company Saegis Pharmaceuticals Inc in early 2007. Lu AE58054 is a potent and selective 5-HT6 receptor antagonist.

H Lundbeck A/S

Ads by Google

You are leaving www.nursinginpractice.com

You are currently leaving the Nursing in Practice site. Are you sure you want to proceed?

Close

Respect for nurses: Sign up to our e-petition TODAY

The Nursing in Practice Respect campaign is now live! Over the coming months, we're set to highlight the vital contribution and efforts of primary care and community care nurses throughout the UK.

As part of our campaign, Nursing in Practice is looking to call on parliament to set up a debate to celebrate the vital work that you do.


GET INVOLVED: SIGN OUR E-PETITION

Close

Calling all primary care nurses! 'Like' our Nursing in Practice Facebook page to enter our free draw to win a £25 M&S voucher




http://www.facebook.com/NursinginPracticeMagazine